Arzoxifene hydrochloride

CAS: 182133-27-3

Ref. 3D-HHA13327

Produktinformation

• Name: Arzoxifene hydrochloride
• Synonyme: 2-(4-Methoxyphenyl)-3-(4-(2-(1-piperidinyl)ethoxy)phenoxy)benzo(b)thiophene-6-ol hydrochloride, 2-(4-Methoxyphenyl)-3-{4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy}-1-Benzothiophene-6-Ol Hydrochloride (1:1), 2-(p-Methoxyphenyl)-3-(p-(2-(1-piperidinyl)ethoxy)phenoxy)benzo(b)thiophene-6-ol hydrochloride, 2-(p-Methoxyphenyl)-3-(p-(2-piperidinoethoxy)phenoxy)benzo(b)thiophene-6-ol hydrochloride, Arzoxifene hydrochloride [USAN], Benzo(b)thiophene-6-ol, 2-(4-methoxyphenyl)-3-(4-(2-(1-piperidinyl)ethoxy)phenoxy)-, hydrochloride, Benzo[b]thiophene-6-ol, 2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-, hydrochloride (1:1), LY 353381 HCl, Ly 353381, Serm 3, Unii-Fu88Pi0433
• CAS: 182133-27-3

Beschreibung

Arzoxifene hydrochloride is a potential anticancer agent that inhibits the activity of integrin receptors. It has been shown to inhibit the growth of estrogen receptor-positive breast cancer cells in vivo, and also reduces the incidence of mammary tumors in rats. Arzoxifene hydrochloride has been shown to inhibit the binding of integrins to their receptors, reducing cell proliferation and preventing tumor metastasis. The drug also binds to estrogen receptors, which may be its mechanism for inhibiting tumor growth. Arzoxifene hydrochloride is a polyunsaturated compound with a chemical structure similar to other drugs used for cancer treatment and autoimmune diseases. This drug has not been shown to have any significant interactions with other drugs, but it does have pharmacological effects on certain cells such as erythrocytes and lymphocytes.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 512.1 g/mol
• Formel: C₂₈H₃₀ClNO₄S
• Reinheit: Min. 95%